Alaska recalls

Certain lots of the Daig Livewire Steerable electrophysiology catheter have incomplete seals on the sterile packaging. This could allow contamination of the device before use. The issue affects specific lot numbers of product number 401904.

Stryker Sustainability Solutions recalled certain reprocessed electrophysiology catheters (Daig Livewire Steerable, Product Number 401652) because the sterile packaging has incomplete seals. An incomplete seal can allow contamination to enter the package, compromising sterility before the device is used.

Stryker Sustainability Solutions identified incomplete seals on sterile packaging for certain Daig Livewire Steerable electrophysiology catheters. This affects 9 units distributed in the US, Canada, and Israel. No injuries have been reported.

Incomplete seals on sterile product

Stryker Sustainability Solutions recalled Daig Livewire Steerable electrophysiology catheters (Product Number 401581) because some units have incomplete seals on their sterile packaging. This affects 108 catheters distributed in the US, Canada, and Israel across multiple lot numbers.

Stryker Sustainability Solutions identified incomplete seals on certain lots of Daig Livewire Steerable reprocessed electrophysiology catheters. The seal defect could allow contamination of the sterile product. Affected units were distributed in the US, Canada, and Israel.

Stryker Sustainability Solutions is recalling certain lots of CS Uni-Directional electrophysiology catheters (Product Number D135304) because some units have incomplete seals on their sterile packaging. An incomplete seal could allow the sterile catheter to become contaminated before use.

Stryker Sustainability Solutions' CS Uni-Directional w Auto ID electrophysiology catheter (Product Number D135303) has incomplete seals on some units, which could compromise sterility. The affected lots were distributed in the US, Canada, and Israel. No injuries have been reported.

Stryker Sustainability Solutions is recalling certain lots of the BW Webster Duo-Decapolar reprocessed electrophysiology catheter due to incomplete seals on the sterile packaging. The incomplete seals could allow contamination of the sterile product before use. A total of 154 units were affected across the US, Canada, and Israel.

Stryker Sustainability Solutions is recalling BARD EP XT Steerable electrophysiology catheters (Product Number 200794) due to incomplete seals on the sterile packaging. The incomplete seals could allow contamination of the sterile device before use. A total of 44 units across multiple lot numbers have been affected.

Stryker Sustainability Solutions is recalling BARD EP XT Decapolar Steerable electrophysiology catheters (Product Number 201007) due to incomplete seals on the sterile packaging. The incomplete seals could allow contamination of the catheter before use. A total of 217 units across multiple lot numbers were distributed in the U.S., Israel, and Canada.

Stryker Sustainability Solutions is recalling certain reprocessed BARD Dynamic XT Steerable electrophysiology catheters due to incomplete seals on the sterile packaging. The incomplete seals may allow contamination of the sterile product before use. This affects 5 units in the US, Canada, and Israel.

Stryker Sustainability Solutions is recalling the BARD Dynamic XT Steerable electrophysiology catheter (Product Number 201103) due to incomplete seals on the sterile packaging. This defect could compromise the sterility of the device. The recall affects specific lot numbers distributed nationwide in the US, as well as in Israel and Canada.

Stryker Sustainability Solutions is recalling BARD Dynamic XT Deca Steerable electrophysiology catheters (Product Number 201102) due to incomplete seals on the sterile packaging. The defect affects 90 units across multiple lot numbers distributed in the US, Canada, and Israel. No injuries have been reported.

Stryker Sustainability Solutions is recalling the BARD Dynamic Tip Steerable catheter (Product Number 6DYNTP001) because some units have incomplete seals on their sterile packaging. This affects 427 units distributed in the US, Canada, and Israel. No injuries have been reported.

Stryker Sustainability Solutions is recalling BARD Dynamic Tip Steerable reprocessed electrophysiology catheters (Product Number 200344) due to incomplete seals on the sterile packaging. The incomplete seals could allow contamination of the sterile device. Affected lot numbers are listed by Stryker, and the recall impacts 28 units distributed in the US, Canada, and Israel.

Stryker Sustainability Solutions is recalling reprocessed BARD Dynamic Tip Steerable electrophysiology catheters (Product Number 200131) due to incomplete seals on the sterile packaging. The incomplete seals may compromise sterility, potentially allowing contamination of the device. Affected lot numbers span from 3966097 to 4762686, with 61 units distributed across the United States, Canada, and Israel.

Stryker Sustainability Solutions has recalled BARD Dynamic Deca Steerable electrophysiology catheters (Product Number 201101) due to incomplete seals on the sterile packaging. The affected catheters may not maintain sterility, which could pose a risk to patients. Approximately 3,063 units in multiple lot numbers are included in this recall.

Integra LifeSciences recalled Codman CerebroFlo EVD Catheters (Product ID 37.550.501, Lot 45322) because testing found endotoxin levels that exceeded safety standards. Endotoxins are bacterial fragments that can trigger harmful immune responses in patients. The affected catheters are used to drain fluid from the brain in hospital settings.

Edwards Lifesciences has updated the labeling for its EVOQUE tricuspid delivery system to include a warning about potential loss of device functionality during valve replacement procedures. This is a labeling change to help clinicians recognize and respond to compromised system performance. No injuries have been reported.

Lot FD1265 of the ZYMUTEST HIA IgG diagnostic kit was shipped with an outdated instruction flyer that contained incorrect values for the positive control. This could lead to misinterpretation of test results if users rely on the wrong reference values.

Bolts and plastic parts on the Cable Hose Carriers that attach cable hoses to the monitor ceiling suspension may loosen or break over time when the monitor is moved or rotated. This affects multiple Azurion 3, 5, and 7 model variants.

Certain lots of the Quidel QuickVue Dipstick Strep A Test may return false positive results, meaning the test could indicate a strep infection when one is not actually present. This could lead to unnecessary antibiotic treatment. The recall affects specific lot numbers distributed across the US.

Hologic's 3DIMENSIONS mammography systems may develop loose, missing, or broken internal bolts over time. This affects multiple model variants distributed nationwide. No injuries have been reported.

Hologic has recalled multiple models of Selenia Dimensions mammography systems because internal bolts can become loose, missing, or broken over time. This may affect the system's structural integrity or function. No injuries have been reported.

Stryker Corporation recalled a limited lot of FluidSmart Urology Tube Sets (REF LL0006) used with fluid management systems in surgical procedures. Some units in this lot did not meet manufacturing standards. No injuries have been reported.

A software defect in the Dexcom ONE+ iOS app (versions 1.5.0 and 1.6.0) can delay glucose value notifications when the app runs in the background. When you open the app, glucose readings may display out of order or the app may incorrectly signal loss of connection. This delay could cause you to miss alerts for dangerously high or low blood sugar, or make treatment decisions based on outdated information.

A software defect in the Dexcom G7 watchOS app (versions 2.9.0–2.11.2) can delay glucose value notifications and alerts when the app runs in the background. When you open the app, older glucose readings may flash on screen, and the app may incorrectly report a loss of signal. This delay could cause you to miss alerts for dangerously high or low blood sugar, or make treatment decisions based on outdated information.

A software defect in the Dexcom G7 continuous glucose monitoring app (versions 2.9.0–2.11.2 for iOS) can delay glucose value updates and alerts when the app runs in the background. When you open the app, notifications may replay in sequence or show outdated readings. In some cases, the app may incorrectly detect signal loss, creating a risk that users could miss high or low blood sugar alerts or make treatment decisions based on outdated information.

Diowave 250W infrared laser systems used for temporary muscle and joint pain relief are operating at a maximum power output of 70W, which exceeds the FDA-cleared limit of 60W. A software update is required to correct the power output to the approved level.